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Although the MHC class II ‘u’ haplotype is strongly associated with type 1 diabetes (T1D) in rats, the role of MHC class II in the
development of tissue-specific autoimmune diseases including T1D and autoimmune thyroiditis remains unclear. To clarify this,
we produced a congenic strain carrying MHC class II ‘a’ and ‘u’ haplotypes on the Komeda diabetes-prone (KDP) genetic
background. The u/u homozygous animals developed T1D similar to the original KDP rat; a/u heterozygous animals did
develop T1D but with delayed onset and low frequency. In contrast, none of the a/a homozygous animals developed T1D;
about half of the animals with a/u heterozygous or a/a homozygous genotypes showed autoimmune thyroiditis. To investigate
the role of genetic background in the development of thyroiditis, we also produced a congenic strain carrying Cblb mutation of
the KDP rat on the PVG.R23 genetic background (MHC class II ‘a’ haplotype). The congenic rats with homozygous Cblb
mutation showed autoimmune thyroiditis without T1D and slight to severe alopecia, a clinical symptom of hypothyroidism such
as Hashimoto’s thyroiditis. These data indicate that MHC class II is involved in the tissue-specific development of autoimmune
diseases, including T1D and thyroiditis.
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Introduction
The major histocompatibility complex (MHC), also known
as human leukocyte antigen (HLA) in human, is asso-
ciated with various autoimmune diseases. Especially,
MHC class II genes show the strongest association with
type 1 diabetes (T1D), in which DRB1*03-DQB1*0201
and DRB1*04-DQB1*0302 haplotypes in Caucasian
and DRB1*0405-DQB1*0401, DRB1*0802-DQB1*0302 and
DRB1*0901-DQB1*0303 haplotypes in Japanese confer
susceptibility to the disease, while DRB1*15-DQB1*0602
haplotype in Caucasian and DRB1*1501-DQB1*0602 and
DRB1*1502-DQB1*0601 haplotypes in Japanese confer
protection against the disease.
1–5
T1D is frequently accompanied by autoimmune
thyroid disease (AITD), such as Graves’ disease (GD)
and Hashimoto’s thyroiditis (HT). The DR3 haplotype
in Caucasian and DRB1*0405-DQB1*0401, DRB1*0802-
DQB1*0302 and DRB1*0901-DQB1*0303 haplotypes in
Japanese confer susceptibility to T1D complicated with
AITD.
6–8
AITD alone is also associated with MHC class II genes.
The DR3 haplotype confers susceptibility to GD and the
DR7 haplotype confers protection against GD,
9,10 in
which arginine at position 74 of DR beta chain exhibits
a strong association with the disease in Caucasian.
11,12
With less confidence, DR3 and DR4 haplotypes are
associated with HT.
13–15
The MHC region shows the strongest susceptibility to
T1D in animal models, such as NOD mice, BB rats, KDP
rats and LEW.1AR1-iddm rats. Almost every rat model
of T1D possesses the same ‘u’ haplotype on the MHC
class II loci (RT1-B, -D), suggesting that the class II ‘u’
haplotype confers susceptibility to T1D in rats. Auto-
immune thyroiditis (also known as HT in humans) with
no clinical manifestation of hypothyroidism is frequently
observed in BB and KDP rats.
16–19 In the analysis of
backcross between BB rats (MHC class II ‘u’ haplotype)
and PVG.R23 rats (‘a’ haplotype), u/u homozygous
animals showed 88% diabetes and 45% thyroiditis; u/a
heterozygous animals showed no diabetes and 64%
thyroiditis, suggesting that ‘u’ haplotype confers sus-
ceptibility to T1D but is susceptible or neutral to
thyroiditis while ‘a’ haplotype confers susceptibility to
thyroiditis but is protective against T1D.
20 In another
report, analysis of F2 intercross between BB and Fischer
rats (‘lv’ haplotype) found that u/u, u/lv and lv/lv
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www.nature.com/geneanimals showed 24, 24 and 0% thyroiditis, respectively,
and analysis of backcross between BB and Lewis rats (‘l’
haplotype) showed that u/u and u/l exhibited 25 and
31% thyroiditis, respectively.
21 These data suggest that
‘u’ haplotype confers susceptibility to thyroiditis, and
acts in a dominant manner against ‘l’ and ‘lv’ haplotypes.
However, these results were based on the mixed genetic
backgrounds such as backcross or intercross progeny.
There has been no data on replacement of genetic
backgrounds through the production of congenic strains.
In KDP rats, thyroiditis frequently develops in animals
showing no or late onset diabetes.
17,19 Thus, although the
‘u’ haplotype is necessary for the development of T1D,
the association of ‘u’ and other haplotypes with T1D and
thyroiditis remains unclear.
To clarify the role of MHC class II in the development
of T1D and thyroiditis, we established and investigated a
congenic strain carrying MHC class II ‘a’ and ‘u’
haplotypes on the KDP genetic background. To investi-
gate the role of genetic background in the development
of thyroiditis, we produced and investigated a congenic
strain carrying Cblb mutation of the KDP rat on the
PVG.R23 genetic background (MHC class II ‘a’ haplo-
type).
Results
Establishment of a KDP.PVG-RT1
a/u congenic strain
By crossing the KDP and PVG.R23 rats followed by 11
successive backcrosses to the KDP, we successfully
produced a congenic strain carrying the MHC class II
‘a’ and ‘u’ haplotypes (heterozygous state) on the KDP
genetic background. Genome-wide profiling revealed
that the region of o14.6Mb between p-terminus and
D20Rat60 on chromosome 20 harboring the MHC class II
region of the PVG.R23 rat had been introgressed into the
KDP genetic background, and that the PVG.R23 genome
was not detected on other chromosomes (Supplementary
Table 1). As the Cblb homozygous mutants have poor
reproductive ability,
17,22 we have been maintaining the
congenic strain having the Cblb region in the hetero-
zygous state.
Incidence of diabetes of the KDP.PVG-RT1
a/u congenic strain
We compared the incidence of T1D among the Cblb
homozygous mutant animals with each of the three
genotypes at MHC class II region in the congenic strain
underthesamespecificpathogen-freecondition(Figure1).
At 300 days of age, 88% (7/8) of u/u homozygous animals
developed T1D similar to the original KDP rat,
22 and
37% (7/19) of a/u heterozygous animals did develop
T1D but with delayed onset and low frequency. In
contrast, none (0/11) of the a/a homozygous animals
developed T1D. The u/u homozygous animals devel-
oped T1D as early as 50 days of age, while the a/u
heterozygous animals developed the disease around 120
days of age at the earliest. Despite the low incidence
and the delay of onset, it is noteworthy that the a/u
heterozygous animals developed T1D.
Degree of insulitis and thyroiditis of the KDP.PVG-RT1
a/u
congenic strain
We then investigated the degree of insulitis and
thyroiditis shortly after the onset of diabetes in diabetic
animals and at 300 days of age in non-diabetic animals
(Figure 2). All of the diabetic animals showed severe
insulitis, whereas non-diabetic animals showed none to
moderate insulitis: 100% (8/8) of u/u homozygous and
84% (16/19) of a/u heterozygous animals developed
slight to severe insulitis. Although none of the a/a
homozygous animals developed T1D, 45% (5/11) of
them exhibited slight to moderate insulitis, suggesting
that ‘a’ haplotype did not confer complete protection
against insulitis. In contrast to the severity of insulitis,
thyroiditis was observed in 0% (0/8), 37% (7/19) and
55% (6/11) of u/u homozygous, a/u heterozygous and
a/a homozygous animals, respectively (Figure 2). The
serum thyroid stimulating hormone (TSH) values seem
to be higher in a/a homozygous and a/u heterozygous
animals than those of u/u homozygous animals, but
there is no significant difference among them (Supple-
mentary Figure 1). Furthermore, all of the TSH values are
in normal range, suggesting no clinical manifestation of
hypothyroidism.
To clarify the development of insulitis and thyroid-
itis in the congenic strain, we further investigated the
degree of insulitis and thyroiditis at 120 days of age
(Figure 3), at which 75% of u/u homozygous animals
developed T1D while none of the a/u heterozygous
animals developed diabetes. Slight to severe insulitis
was observed in 100% (10/10), 83% (10/12) and 27%
(3/11) of u/u homozygous, a/u heterozygous and a/a
homozygous animals, respectively, the severity of which
was milder than that at 300 days of age. At the same
age, thyroiditis was observed in 20% (2/10), 8% (1/12)
and 9% (1/11) of u/u homozygous, a/u heterozygous
and a/a homozygous animals, respectively. The degree
of thyroiditis was much milder than that of insulitis,
suggesting that insulitis develops earlier than thyroiditis
in these animals.
Establishment of a PVG.KDP-Cblb congenic strain
By crossing the KDP and PVG.R23 rats followed by
seven successive backcrosses to the PVG.R23, we
successfully produced a congenic strain carrying the
mutated Cblb allele of the KDP rat on the PVG.R23
genetic background (MHC class II ‘a’ haplotype).
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Figure 1 Cumulative incidence of diabetes in the KDP.PVG-RT1
a/u
congenic strain. Under the same specific pathogen-free condition,
data of diabetes onset were obtained from the u/u homozygous
(n¼8), a/u heterozygous (n¼19) and a/a homozygous (n¼11)
animals, all of which harbor the homozygous Cblb mutation.
Po0.001 for u/u vs a/u and u/u vs a/a, and P¼0.027 for a/u vs
a/a by log-rank tests.
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Genes and ImmunityGenome-wide profiling revealed that the region of
o42.2Mb between D11Rat13 and D11Rat37 on chromo-
some 11 harboring the mutated Cblb allele of the KDP rat
had been introgressed into the PVG.R23 genetic back-
ground, and that the KDP genome was not detected on
other chromosomes (Supplementary Table 1). As the Cblb
homozygous mutants have poor reproductive ability,
17,22
we have been maintaining the congenic strain having the
Cblb region in the heterozygous state.
Degree of insulitis and thyroiditis of the PVG.KDP-Cblb
congenic strain
As expected, none of the animals in this congenic strain
developed T1D before 300 days of age. We investigated
the degree of insulitis and thyroiditis at 300 days of age,
and found that 19% (4/21) of the Cblb homozygous
mutants showed only slight insulitis, whereas hetero-
zygous (n¼10) and wild-type (n¼10) animals exhibited
no insulitis (Figure 4). At the same age, thyroiditis was
observed in 38% (8/21) of the Cblb homozygous mutant
animals, whereas none of the heterozygous (n¼10) or
wild-type (n¼10) animals showed thyroiditis (Figure 4).
The degree of insulitis and thyroiditis of the Cblb
homozygous mutant animals is similar to that of a/a
homozygous animals in the KDP.PVG-RT1
a/u congenic
strain. There is no significant difference in the serum TSH
values among animals with three genotypes of Cblb
(Supplementary Figure 1) and all of the TSH values are in
normal range, suggesting no clinical symptom of hy-
pothyroidism. However, there was one Cblb homozygous
mutant animal exhibiting an exceptionally high TSH
value of more than 200 ngml
 1. This animal also showed
severe thyroiditis and severe hair loss (alopecia), indicat-
ing clinical manifestation of hypothyroidism such as HT.
Effect of iodide on the development of thyroiditis in the
congenic strains
The NOD-H2
h4 mice, which express MHC class II ‘k’
haplotype on the NOD background, do not develop
T1D but spontaneous autoimmune thyroiditis, which is
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Figure 2 Degree of insulitis and thyroiditis in the KDP.PVG-RT1
a/u congenic strain at 300 days of age. (A): Representative histology of
the pancreas and thyroid glands in the congenic strain. a, normal islet; b, mild insulitis; c, severe insulitis; d, normal thyroid glands;
e, mild thyroiditis; f, severe thyroiditis. (B) The degree of insulitis and thyroiditis in the congenic strain shortly after the onset of diabetes
or at 300 days of age for non-diabetic animals. Data were obtained from the u/u homozygous (n¼8), a/u heterozygous (n¼19) and a/a
homozygous (n¼11) animals, all of which harbor the homozygous Cblb mutation. Insulitis: P¼0.017 for u/u vs a/u, Po0.001 for u/u vs
a/a and P¼0.020 for a/u vs a/a; Thyroiditis: P¼0.050 for u/u vs a/u, P¼0.016 for u/u vs a/a and P¼0.573 for a/u vs a/a by
Mann–Whitney U tests.
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Genes and Immunityaccelerated by adding iodide in the drinking water.
23
To clarify the effect of iodide on the development of
thyroiditis in the congenic strains, we supplied animals
with 0.15% NaI in the drinking water for 4 weeks around
200 days of age. In the KDP.PVG-RT1
a/u congenic strain,
thyroiditis was observed in 60% (6/10) and 27% (3/11) of
a/u heterozygous and a/a homozygous animals, respec-
tively (Figure 5). In the PVG.KDP-Cblb congenic strain,
thyroiditis was observed in 50% (6/12) of the Cblb
homozygous mutant animals (Figure 5). As there was no
significant acceleration in the development of thyroiditis
with iodide treatment for 4 weeks, we did not measure
TSH levels in these animals.
Discussion
In the present study, we investigated the role of MHC
class II in the development of tissue-specific autoimmune
diseases including T1D and autoimmune thyroiditis by
use of newly established congenic strains. The results
indicate that, under homozygosity for Cblb mutation,
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Figure 3 Degree of insulitis and thyroiditis in the KDP.PVG-RT1
a/u congenic strain at 120 days of age. The degree of insulitis and thyroiditis
in each animal was evaluated shortly after the onset of diabetes or at 120 days of age for non-diabetic animals. Data were obtained from the
u/u homozygous (n¼10), a/u heterozygous (n¼12) and a/a homozygous (n¼11) animals, all of which harbor the homozygous Cblb
mutation. Insulitis at 300 days vs 120 days: P¼0.184 for u/u, P¼0.202 for a/u and P¼0.280 for a/a; Thyroiditis at 300 days vs 120 days:
P¼0.193 for u/u, P¼0.055 for a/u and P¼0.018 for a/a by Mann–Whitney U tests.
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Figure 4 Degree of insulitis and thyroiditis in the PVG.KDP-Cblb congenic strain at 300 days of age. The degree of insulitis and thyroiditis in
each animal was evaluated at 300 days of age. Data were obtained from the animals homozygous (n¼21), heterozygous (n¼10) and wild
type (n¼10) for the Cblb mutation. P¼0.082 for insulitis and P¼0.249 for thyroiditis by Mann–Whitney U tests in comparison between the
a/a homozygous animals in the KDP.PVG-RT1
a/u congenic strain and the Cblb homozygous mutants in the PVG.KDP-Cblb congenic strain.
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Genes and ImmunityMHC class II ‘u’ haplotype confers susceptibility to
insulitis and T1D, while ‘a’ haplotype confers protection
against insulitis and T1D, in which ‘u’ haplotype acts in a
semidominant manner with respect to ‘a’ haplotype. In
contrast, under homozygosity for Cblb mutation, MHC
class II ‘u’ haplotype confers neutral susceptibility to
thyroiditis, while ‘a’ haplotype confers susceptibility to
thyroiditis, in which ‘a’ haplotype acts in a dominant
or semidominant manner with respect to ‘u’ haplotype.
It should be noted that it is not T1D but thyroiditis that
occurs in congenic rats with homozygosity for both MHC
class II ‘a’ haplotype and Cblb mutation. These findings
support the previous report on the analysis of backcross
between BB and PVG.R23 rats
20 but further clarifies the
mode of inheritance of ‘a’ and ‘u’ haplotypes on the KDP
genetic background. The length of the congenic interval
found in each congenic strain varied. The relatively small
cohort sizes of these experiments were underpowered to
detect small effects caused by the congenic intervals.
Larger cohorts are needed to detect more subtle effects of
congenic intervals in T1D and thyroiditis.
To our knowledge, this study is the first analysis of
the role of rat MHC class II haplotypes in the develop-
ment of T1D and autoimmune thyroiditis in a genetic
background susceptible to T1D using congenic strains.
In addition to the BB, KDP and LEW.1AR1-iddm rats,
spontaneous T1D also occurs (with a frequency of 2%)
in LEW.1WR1 rats.
24 Almost all spontaneous or virus-
induced T1D models in rat species possess ‘u’ haplotype
at MHC class II,
25 suggesting that the MHC class II ‘u’
haplotype is required to develop T1D in rats. In humans,
non-aspartic acid at position 57 of HLA-DQ beta chain of
MHC class II is associated with T1D.
26 At position 57 of
rat RT1-B beta, which is orthologous to HLA-DQ beta,
the ‘u’ allele possesses non-aspartic acid, while ‘a’ allele
possesses aspartic acid.
27 These findings indicate that
the MHC class II molecule encoded by ‘u’ but not ‘a’
haplotype recognizes an unidentified epitope, among
which an insulin epitope is the strong candidate,
28,29 and
leads to islet-specific autoimmunity, resulting in T1D.
In humans, arginine at position 74 of HLA-DR beta
chain of MHC class II has been reported to be strongly
associated with GD.
11 At position 74 of rat RT1-D beta,
which is orthologous to HLA-DR beta, both the ‘u’ and
‘a’ alleles possess alanine.
27 These indicate that both
haplotypes are not likely to be susceptible to GD.
Although there are no such data for HT, ‘a’ but not ‘u’
haplotype would be expected to possess amino acid(s)
that confer susceptibility to HT. There has been no
known spontaneous animal model exhibiting final
pathophysiological states of AITD, including GD and
HT. Although the BB and KDP rats show spontaneous
autoimmune thyroiditis, they do not develop hypothy-
roidism. In this study, we also investigated whether
combination of the thyroiditis-susceptible MHC class II
haplotype ‘a’ and the autoimmunity-susceptible Cblb
mutation could induce hypothyroidism on two different
genetic backgrounds such as the KDP and PVG.R23.
Although 40–60% of animals in both strains developed
thyroiditis, the TSH levels suggested no clinical symp-
tom of hypothyroidism. However, in the PVG.KDP-Cblb
congenic strain, 76% (16/21) of the Cblb homozygous
mutant animals showed slight to severe alopecia, which
is often found to be associated with hypothyroidism in
humans. Only 19% (4/21) of these animals developed
severe alopecia, while the others exhibited only slight to
mild states. Furthermore, regrowth occurred sponta-
neously in many cases and the hair growth was restored
within several months. These findings suggest the use of
the PVG.KDP-Cblb congenic strain as a spontaneous
animal model of HT. However, the low frequency of
incidence of severe pathophysiological states makes
practical use of this model difficult; iodide supplement
from younger age and longer duration might induce
hypothyroidism more frequently.
In conclusion, the roles of rat MHC class II ‘a’ and ‘u’
haplotype in the development of T1D and autoimmune
thyroiditis differ. The congenic strains established in this
study will be useful for the investigation of the
pathogenesis and pathophysiology of tissue-specific
autoimmune diseases, including T1D and thyroiditis.
Materials and methods
KDP and PVG.R23 rats
Both KDP (RT1.A
uB
uD
uC
u) and PVG.R23 (RT1.A
uB
aD
aC
av1)
rats were a kind gift from Dr K Komeda (Tokyo Medical
University), and were maintained at the Institute for Experi-
mental Animals, Kobe University School of Medicine.
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Figure 5 Degree of thyroiditis in the KDP.PVG-RT1
a/u and
PVG.KDP-Cblb congenic strains with iodide treatment. The degree
of thyroiditis in each animal was evaluated after 4 weeks of iodide
treatment. Data were obtained from the a/u heterozygous (n¼10)
and a/a homozygous (n¼11) animals in the KDP.PVG-RT1
a/u
congenic strain, all of which harbor the homozygous Cblb mutation,
and from the Cblb homozygous mutant animals (n¼12) in the
PVG.KDP-Cblb congenic strain. Thyroiditis in NaI treatment vs no
treatment: P¼0.682 for a/u heterozygous animals in the KDP.PVG-
RT1
a/u congenic strain, P¼0.218 for a/a homozygous animals in
the KDP.PVG-RT1
a/u congenic strain and P¼0.355 for the Cblb
homozygous mutants in the PVG.KDP-Cblb congenic strain by
Mann–Whitney U tests.
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All animals were maintained under specific pathogen-
free conditions at 23±21Ca n d5 5 ±10% relative humidity
with a 12-h light–dark cycle, and were provided with
water and a commercial diet CE-2 (CLEA Japan, Inc.,
Tokyo, Japan) at the Institute for Experimental Animals,
Kobe University School of Medicine. All animal experi-
ments were approved by the Committee on Animal
Experimentation, Kobe University School of Medicine,
and carried out in accordance with the ‘Guidelines for
Animal Experimentation at Kobe University’.
KDP.PVG-RT1
a/u congenic strain
The KDP and PVG.R23 rats were crossed to produce the
F1 progeny. Eleven successive backcrosses (N12) to the
KDP rats were needed to obtain animals heterozygous at
MHC class II region but homozygous for KDP allele for
the other regions. The Cblb region has been maintained in
the heterozygous state to overcome the poor reproductive
ability of the Cblb homozygous mutants.
17,22 An intercross
between the N12 animals was conducted to obtain the con-
genic strain (N12F1) carrying MHC class II (RT1-B, -D)
‘a’ and ‘u’ haplotypes on the KDP genetic background.
The congenic strain, named KDP.PVG-RT1
a/u/Nyo, is
available from the National Bio-Resource Project of Rat
in Japan (http://www.anim.med.kyoto-u.ac.jp/nbr/).
PVG.KDP-Cblb congenic strain
The KDP and PVG.R23 rats were crossed to produce
the F1 progeny. Seven successive backcrosses (N8) to
the PVG.R23 rats were needed to obtain animals
heterozygous at the Cblb region but homozygous for
PVG.R23 allele for the other regions. An intercross
between the N8 animals was conducted to obtain the
congenic strain (N8F1) carrying the mutated Cblb allele
of the KDP rat on the PVG.R23 genetic background. The
congenic strain, named PVG.KDP-Cblb/Nyo, is available
from the National Bio-Resource Project of Rat in Japan
(http://www.anim.med.kyoto-u.ac.jp/nbr/).
Genotyping
The simple sequence length polymorphism markers
and PCR–RFLP markers used in this study have been
described (Rat Genome Database, available at http://
rgd.mcw.edu/).
17,22,30,31 Genotyping was performed as
described in previous investigations.
17,22,30,31 Briefly,
genomic DNA was extracted from the tail tip of each
rat using the automatic DNA Isolation System (Kurabo,
Osaka, Japan). PCR amplification was carried out using
200-nM sense and antisense primers, 200mM each dNTP,
12-ng genomic DNA and 0.75U of LA Taq DNA poly-
merase (Takara Bio Inc., Shiga, Japan) in a total volume
of 15ml. The PCR product was mixed with loading buffer
(0.03% bromphenol blue and 30% glycerol), electropho-
resed on 4% NuSieve 3:1 agarose gel (FMC BioProducts,
Rockland, ME, USA) and stained with ethidium bromide.
For Cblb, genotyping was performed by PCR–RFLP ana-
lysis using primers, 50-TGCCCCTTCTGTCGCTGTGA-30
and 50-CCTCGGTTTTGAATCAACAG-30, and restriction
enzyme TaqI. For D20Rwh1 (RT1-Bb), genotyping was
performed by PCR–RFLP analysis using primers, 50-CAC
CAACGGGACGCAGCGCAT-30 and 50-CAAGCCGCCG
CAGGGAGGTG-30, and restriction enzyme BssHII. For
RT1-Db, genotyping was performed by PCR–RFLP ana-
lysis using primers, 50-ACGCAGCGCGTGCGGCTTCT-30
and 50-GCTCCATGAACTCCTTCTGTTTG-30, and restric-
tion enzyme DdeI.
Phenotyping of diabetes
Phenotyping was completed using a previously described
protocol.
30 Diabetes was defined as glycosuria positivity
and blood glucose levels X250mgdl
 1 under ad libitum
dietary conditions. Data were obtained from two gener-
ations (N12F1 to N12F2) of the KDP.PVG-RT1
a/u congenic
strain and two generations (N8F2 to N8F3) of the
PVG.KDP-Cblb congenic strain.
Histological analysis
Histological analysis was performed as described previ-
ously
17,30 with some modifications. Briefly, tissues were
fixed in 10% formalin, and paraffin sections were stained
with hematoxylin and eosin. Serial sections were viewed
via light microscopy by an examiner blind to the experi-
mental conditions of the animals. Each animal was rated
on the degree of insulitis, which ranged from none to
severe (none [0%], slight [0%oand lower than or equal
to 5%], mild [5%oand lower than or equal to 20%],
moderate [20%oand lower than or equal to 70%],
and severe [70%o]) based mainly on the percentage of
moderately and severely infiltrated islets. The term
‘slight insulitis’ refers to at least one infiltrated islet
across the sections and a percentage of infiltrated islets
of 5% or less. Animals were also rated on the degree of
thyroiditis, which ranged from none to severe (none,
slight-mild and moderate-severe) based on the percen-
tage of infiltrated regions in the thyroid sections. Data
were obtained from two generations (N12F1 to N12F2) of
the KDP.PVG-RT1
a/u congenic strain and two generations
(N8F2 to N8F3) of the PVG.KDP-Cblb congenic strain, with
the exception that the degree of insulitis and thyroiditis at
120 days of age was evaluated in the N12F5 generation of
the KDP.PVG-RT1
a/u congenic strain.
TSH assay
Serum TSH was measured with an enzyme-linked immuno-
sorbent assay kit (Rat TSH ELISA KIT, Shibayagi, Gunma,
Japan).
Iodide administration
The a/u heterozygous and a/a homozygous animals in
the KDP.PVG-RT1
a/u congenic strain and the Cblb homo-
zygous mutant animals in the PVG.KDP-Cblb congenic
strain were supplied with 0.15% NaI in the drinking
water for 4 weeks around 200 days of age.
Statistical analysis
Differences in the incidence of diabetes were assessed
using log-rank tests. Differences in the degree of insulitis
or thyroiditis were assessed using Mann–Whitney U tests.
Differences in the TSH values were assessed using Tukey–
Kramer method. Statistical analysis was performed by R.
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